Business
Agios sells rights to royalties on sale of cancer drug Tibsovo in US for $131.8 million
Agios sells rights to royalties on sale of cancer drug Tibsovo in US for $131.8 million
Agios sells rights to royalties on sale of cancer drug Tibsovo in US for $131.8 million